Meningococcal vaccine groups A C Y W-135 polysaccharide: Lack of efficacy in meningococcus prevention: case report

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1421, 2012-01, pp. : 36-36

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vaccines: Hyperhaemolysis (first reports with meningococcal vaccine groups A C Y W-135 polysaccharide and Hib vaccine conjugate) in an EBV-infected patient: case report

Reactions Weekly, Vol. 1, Iss. 1278, 2009-01 ,pp. : 29-30

Adis International

Access to resources Recommend Favorite

Meningococcal vaccine groups A C Y W-135 conjugate: Guillain Barre syndrome: case report

Reactions Weekly, Vol. 1, Iss. 1135, 2007-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Meningococcal vaccine groups A C Y W-135 conjugate: Guillain-Barré syndrome: 5 case reports

Reactions Weekly, Vol. 1, Iss. 1082, 2005-01 ,pp. : 18-19

Adis International

Access to resources Recommend Favorite

Meningococcal vaccine groups A C Y W-135 conjugate: Guillain-Barré syndrome: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1100, 2006-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Meningococcal Quadrivalent (Serogroups A, C, W135, and Y) Conjugate Vaccine (Menveo®)†: Profile Report

By Deeks Emma D.

Pediatric Drugs, Vol. 14, Iss. 1, 2012-02 ,pp. : 63-65

Adis International

Access to resources Recommend Favorite